Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMP010 + AS01B in malaria-experienced adults
NCT02458092Phase 1Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Apr 2008
- Primary completion
- Dec 2008
- Modality
- Therapeutic Vaccines, Recombinant Protein Vaccines
01
Overview
Phase 1, randomised, double-blind trial of FMP010 in malaria (2 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Number of Participants With Solicited Adverse Events at Day 7, Number of Subjects With Unsolicited Adverse Events and 1 more. Started Apr 2008; status: completed.
02
Drugs
FMP010
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02458092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458092.